PDSB Stephen C Glover buys $0 worth of shares
Mar 27, 2025, 10:32 AM
0.00%
What does PDSB do
PDS Biotechnology, based in Princeton, New Jersey, develops clinical-stage immunotherapies for various cancers, including its lead product PDS0101, which targets HPV16. The company went public on October 1, 2015, and has 25 employees.
Stephen C Glover bought 30,122 shares of PDSB on 28 February at $0.00 per share, worth a total of $0. They now own 78,851 PDSB shares, or a 62% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.